Kerr launches hemostatic agent

Kerr Dental has introduced a new hemostatic agent for use with moderate bleeding where gingival retraction is not required.

Hemostasyl requires less material compared to competing hemostatic agents, Kerr said in a press release.

Hemostasyl syringe. Image courtesy of Kerr.

"With Hemostasyl, doctors now have a material that is incredibly easy to dispense using a convenient syringe delivery and a viscosity that stays in place and controls blood and other fluids well," said product manager James Lobsenz.

Hemostasyl is brightly colored so it is easy to see and clean up, and its composition helps adhere to soft and hard tissue with ease, the company said.

With a concentration of 15% aluminum chloride, this material is intended to stop bleeding in many clinical applications such as Class V composite placement, cementation, and scaling in perio cases.

Unlike some competing products, Hemostasyl contains no ferric sulfate, an ingredient that can stain proteins black, including soft tissue and dentin.